Cargando…
In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium
Oculocutaneous albinism (OCA) encompasses a set of autosomal recessive genetic conditions that affect pigmentation in the eye, skin, and hair. OCA patients display reduced best-corrected visual acuity, reduced to absent ocular pigmentation, abnormalities in fovea development, and/or abnormal decussa...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758966/ https://www.ncbi.nlm.nih.gov/pubmed/35021041 http://dx.doi.org/10.1016/j.stemcr.2021.11.016 |
_version_ | 1784633014747136000 |
---|---|
author | George, Aman Sharma, Ruchi Pfister, Tyler Abu-Asab, Mones Hotaling, Nathan Bose, Devika DeYoung, Charles Chang, Justin Adams, David R. Cogliati, Tiziana Bharti, Kapil Brooks, Brian P. |
author_facet | George, Aman Sharma, Ruchi Pfister, Tyler Abu-Asab, Mones Hotaling, Nathan Bose, Devika DeYoung, Charles Chang, Justin Adams, David R. Cogliati, Tiziana Bharti, Kapil Brooks, Brian P. |
author_sort | George, Aman |
collection | PubMed |
description | Oculocutaneous albinism (OCA) encompasses a set of autosomal recessive genetic conditions that affect pigmentation in the eye, skin, and hair. OCA patients display reduced best-corrected visual acuity, reduced to absent ocular pigmentation, abnormalities in fovea development, and/or abnormal decussation of optic nerve fibers. It has been hypothesized that improving eye pigmentation could prevent or rescue some of the vision defects. The goal of the present study was to develop an in vitro model for studying pigmentation defects in human retinal pigment epithelium (RPE). We developed a “disease in a dish” model for OCA1A and OCA2 types using induced pluripotent stem cells to generate RPE. The RPE is a monolayer of cells that are pigmented, polarized, and polygonal in shape, located between the neural retina and choroid, with an important role in vision. Here we show that RPE tissue derived in vitro from OCA patients recapitulates the pigmentation defects seen in albinism, while retaining the apical-basal polarity and normal polygonal morphology of the constituent RPE cells. |
format | Online Article Text |
id | pubmed-8758966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87589662022-01-19 In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium George, Aman Sharma, Ruchi Pfister, Tyler Abu-Asab, Mones Hotaling, Nathan Bose, Devika DeYoung, Charles Chang, Justin Adams, David R. Cogliati, Tiziana Bharti, Kapil Brooks, Brian P. Stem Cell Reports Resource Oculocutaneous albinism (OCA) encompasses a set of autosomal recessive genetic conditions that affect pigmentation in the eye, skin, and hair. OCA patients display reduced best-corrected visual acuity, reduced to absent ocular pigmentation, abnormalities in fovea development, and/or abnormal decussation of optic nerve fibers. It has been hypothesized that improving eye pigmentation could prevent or rescue some of the vision defects. The goal of the present study was to develop an in vitro model for studying pigmentation defects in human retinal pigment epithelium (RPE). We developed a “disease in a dish” model for OCA1A and OCA2 types using induced pluripotent stem cells to generate RPE. The RPE is a monolayer of cells that are pigmented, polarized, and polygonal in shape, located between the neural retina and choroid, with an important role in vision. Here we show that RPE tissue derived in vitro from OCA patients recapitulates the pigmentation defects seen in albinism, while retaining the apical-basal polarity and normal polygonal morphology of the constituent RPE cells. Elsevier 2022-01-11 /pmc/articles/PMC8758966/ /pubmed/35021041 http://dx.doi.org/10.1016/j.stemcr.2021.11.016 Text en © 2021. https://creativecommons.org/licenses/by-nc-nd/3.0/igo/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/igo/). |
spellingShingle | Resource George, Aman Sharma, Ruchi Pfister, Tyler Abu-Asab, Mones Hotaling, Nathan Bose, Devika DeYoung, Charles Chang, Justin Adams, David R. Cogliati, Tiziana Bharti, Kapil Brooks, Brian P. In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium |
title | In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium |
title_full | In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium |
title_fullStr | In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium |
title_full_unstemmed | In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium |
title_short | In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium |
title_sort | in vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium |
topic | Resource |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758966/ https://www.ncbi.nlm.nih.gov/pubmed/35021041 http://dx.doi.org/10.1016/j.stemcr.2021.11.016 |
work_keys_str_mv | AT georgeaman invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT sharmaruchi invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT pfistertyler invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT abuasabmones invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT hotalingnathan invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT bosedevika invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT deyoungcharles invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT changjustin invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT adamsdavidr invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT cogliatitiziana invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT bhartikapil invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium AT brooksbrianp invitrodiseasemodelingofoculocutaneousalbinismtype1and2usinghumaninducedpluripotentstemcellderivedretinalpigmentepithelium |